May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated ...
The U.S. ‌FDA's advisory ‌panel on Thursday ​voted in favor of recommending ‌that ⁠COVID-19 vaccines for the ⁠2026-2027 ...
Experts skipped the cicada variant BA.3.2 and last year’s LP.8.1 vaccine strain and recommended monovalent XFG option.
A new, "highly mutated" COVID strain is quickly gaining ground in the United States, according to new data. Variant BA.3.2, nicknamed "Cicada," first drew the attention of health officials earlier ...
A COVID-19 variant that has remained "underground" for years is catching the attention of health officials in the United States and abroad. The Centers for Disease Control and Prevention (CDC) said in ...
This fall’s updated COVID-19 vaccines should target the SARS-CoV-2 XFG variant, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) said ...
The variant was first identified in November 2024 in South Africa. It is a descendant of BA.3, an Omicron subvariant that emerged in 2022 and briefly co-circulated with BA.1 and BA.2, per the CDC.
The FDA's Vaccine and Related Biological Products Advisory Committee will convene with its membership unchanged by Robert F.